About Immune IQ
Immune IQ is a company based in Minneapolis (United States) founded in 2008 by David Deetz and Barbara Roth.. Immune IQ has raised $54.99 million across 7 funding rounds from investors including LabCorp, Dian Diagnostics and Ping An Ventures. Immune IQ offers products and services including Immune Reveal and AI Decoding Engine. Immune IQ operates in a competitive market with competitors including NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic, among others.
- Headquarter Minneapolis, United States
- Founders David Deetz, Barbara Roth
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$54.99 M (USD)
in 7 rounds
-
Latest Funding Round
$15.86 M (USD), Series A
Jan 27, 2022
-
Investors
LabCorp
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Immune IQ
Immune IQ offers a comprehensive portfolio of products and services, including Immune Reveal and AI Decoding Engine. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI-powered analyzer for early disease detection via immune system scanning.
System for deciphering immune data to identify diseases accurately.
Funding Insights of Immune IQ
Immune IQ has successfully raised a total of $54.99M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $15.86 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $15.9M
-
First Round
First Round
(13 Jul 2012)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series A - Immune IQ | Valuation |
investors |
|
| Feb, 2020 | Amount | Seed - Immune IQ | Valuation |
investors |
|
| Jul, 2017 | Amount | Seed - Immune IQ | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Immune IQ
Immune IQ has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Dian Diagnostics and Ping An Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Immune IQ
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Immune IQ
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immune Iq Comparisons
Competitors of Immune IQ
Immune IQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuvoAir, QuidelOrtho, BioSerenity, ProciseDx and Neurosynaptic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical decision support tools for respiratory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Provider of healthcare information services
|
|
| domain | founded_year | HQ Location |
Provider of smart healthcare solutions for sleep and EEG lab management
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
|
| domain | founded_year | HQ Location |
ICT-based products and solutions are developed for healthcare.
|
|
| domain | founded_year | HQ Location |
Remote patient monitoring software is developed for healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Immune IQ
When was Immune IQ founded?
Immune IQ was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is Immune IQ located?
Immune IQ is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Who is the current CEO of Immune IQ?
David Deetz is the current CEO of Immune IQ. They have also founded this company.
Is Immune IQ a funded company?
Immune IQ is a funded company, having raised a total of $54.99M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.59M, raised on Jul 13, 2012.
What does Immune IQ do?
Immune IQ was founded in 2008 and is based in Minneapolis, United States. A diagnostic platform focused on immune diseases is operated within the health technology sector. The Immune Reveal platform is utilized to analyze health status and disease data directly from a patients immune system. Rapid diagnosis of critical conditions is facilitated through this point-of-care approach, supporting clinical decision-making in various settings.
Who are the top competitors of Immune IQ?
Immune IQ's top competitors include MedTel Healthcare, QuidelOrtho and Neurosynaptic.
What products or services does Immune IQ offer?
Immune IQ offers Immune Reveal and AI Decoding Engine.
Who are Immune IQ's investors?
Immune IQ has 7 investors. Key investors include LabCorp, Dian Diagnostics, Ping An Ventures, Hermed Capital, and GIMDX.